Literature DB >> 15526308

Neuropsychological performance in early and late onset Alzheimer's disease: comparisons in a memory clinic population.

Srinivas Suribhatla1, Sarah Baillon, Michael Dennis, Mangesh Marudkar, Saquib Muhammad, Dena Munro, Christine Spreadbury, James Lindesay.   

Abstract

OBJECTIVES: To compare the neuropsychological performance associated with early and late onset Alzheimer's disease (AD), in order to identify differences and compare these with previous reports.
METHODS: Patients attending a memory clinic were given a detailed multi-disciplinary diagnostic assessment, including a battery of neuropsychological tests. From those meeting ICD-10 criteria for Alzheimer's disease (AD), an early-onset (EO) group (n = 40) and a late-onset (LO) group (n = 90) were identified, and their performances compared. Patients with mixed dementia and co-morbid depression were excluded.
RESULTS: After adjustment, the EO and LO groups performed at a comparable level on the majority of the neuropsychological tests. The LO group performed better on the WAIS digit span test, AMIPB Complex Design and the written picture description, and the EO group performed better on the WAIS similarities test and the Boston naming test.
CONCLUSIONS: These findings suggest that, after adjusting for overall dementia severity and pre-morbid IQ, there is greater fronto-parietal/right hemisphere involvement in early-onset AD, and greater temporal/left hemisphere involvement in late-onset AD. This may be due to different genetic risk profiles for AD at different ages. Copyright (c) 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15526308     DOI: 10.1002/gps.1196

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  13 in total

1.  Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer's disease.

Authors:  Natalie C Kaiser; Rebecca J Melrose; Collin Liu; David L Sultzer; Elvira Jimenez; Michael Su; Lorena Monserratt; Mario F Mendez
Journal:  Am J Alzheimers Dis Other Demen       Date:  2012-09-17       Impact factor: 2.035

2.  Nonamnestic presentations of early-onset Alzheimer's disease.

Authors:  Mario F Mendez; Albert S Lee; Aditi Joshi; Jill S Shapira
Journal:  Am J Alzheimers Dis Other Demen       Date:  2012-08-07       Impact factor: 2.035

3.  Comparison of clinical characteristics between familial and non-familial early onset Alzheimer's disease.

Authors:  Aditi Joshi; John M Ringman; Albert S Lee; Kevin O Juarez; Mario F Mendez
Journal:  J Neurol       Date:  2012-03-30       Impact factor: 4.849

4.  Alzheimer's disease first symptoms are age dependent: Evidence from the NACC dataset.

Authors:  Josephine Barnes; Bradford C Dickerson; Chris Frost; Lize C Jiskoot; David Wolk; Wiesje M van der Flier
Journal:  Alzheimers Dement       Date:  2015-04-24       Impact factor: 21.566

5.  Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum.

Authors:  R Migliaccio; F Agosta; K Rascovsky; A Karydas; S Bonasera; G D Rabinovici; B L Miller; M L Gorno-Tempini
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

6.  In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.

Authors:  William C Kreisl; Chul Hyoung Lyoo; Meghan McGwier; Joseph Snow; Kimberly J Jenko; Nobuyo Kimura; Winston Corona; Cheryl L Morse; Sami S Zoghbi; Victor W Pike; Francis J McMahon; R Scott Turner; Robert B Innis
Journal:  Brain       Date:  2013-06-17       Impact factor: 13.501

7.  Medial temporal atrophy in early and late-onset Alzheimer's disease.

Authors:  Enrica Cavedo; Michela Pievani; Marina Boccardi; Samantha Galluzzi; Martina Bocchetta; Matteo Bonetti; Paul M Thompson; Giovanni B Frisoni
Journal:  Neurobiol Aging       Date:  2014-03-15       Impact factor: 4.673

8.  Association of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia.

Authors:  Amy E Sanders; Cuiling Wang; Mindy Katz; Carol A Derby; Nir Barzilai; Laurie Ozelius; Richard B Lipton
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272

9.  Should EOAD patients be included in clinical trials?

Authors:  Kinga Szigeti; Rachelle S Doody
Journal:  Alzheimers Res Ther       Date:  2011-02-08       Impact factor: 6.982

10.  Differences between Early and Late-Onset Alzheimer's Disease in Neuropsychological Tests.

Authors:  Francisca Sá; Paula Pinto; Catarina Cunha; Raquel Lemos; Liliana Letra; Mário Simões; Isabel Santana
Journal:  Front Neurol       Date:  2012-05-14       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.